BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35504036)

  • 1. Apoptosis-related genes-based prognostic signature for osteosarcoma.
    Yang F; Zhang Y
    Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
    Tian K; Qi W; Yan Q; Lv M; Song D
    Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
    Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
    Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma.
    Ge Z; Song D
    Medicine (Baltimore); 2022 Dec; 101(50):e32083. PubMed ID: 36550843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma.
    Xiao KW; Liu ZB; Zeng ZH; Yan FF; Xiao LF; Li JL; Cai L
    J Oncol; 2021; 2021():9967954. PubMed ID: 34188683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma.
    Wang B; Sun Y
    Pathol Oncol Res; 2022; 28():1610047. PubMed ID: 35153625
    [No Abstract]   [Full Text] [Related]  

  • 16. A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.
    Yang W; Wu H; Tong L; Wang Y; Guo Q; Xu L; Yan H; Yin C; Sun Z
    Front Oncol; 2022; 12():1015094. PubMed ID: 36276092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 18. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFNG is an independent prognostic marker for osteosarcoma.
    Gao Y; Luo L; Qu Y; Zhou Q
    Eur J Med Res; 2023 Jul; 28(1):256. PubMed ID: 37496053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration.
    Fu Y; Jin Z; Shen Y; Zhang Z; Li M; Liu Z; He G; Wu J; Wen J; Bao Q; Wang J; Zhang W
    Transl Oncol; 2022 Aug; 22():101452. PubMed ID: 35598382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.